Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Environment may play significant role in multiple sclerosis.
Diverse functional roles of lipocalin-2 in the central nervous system.
Immunological differences between classical phenothypes of multiple sclerosis.
Towards a Classification Approach using Meta-Biclustering: Impact of Discretization in the Analysis of Expression Time Series.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica.
High-Affinity Binding of Remyelinating Natural Autoantibodies to Myelin-Mimicking Lipid Bilayers Revealed by Nanohole Surface Plasmon Resonance.
ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres.
B-89Comparison of Driving Performance, Cognition, and Physical Symptoms in Individuals with Multiple Sclerosis and Healthy Controls.
Laquinimod, a once-daily oral drug in development for the treatment of relapsing-remitting multiple sclerosis.
[CHANGES IN THE QUALITATIVE AND QUANTITATIVE COMPOSITION OF GUT MICROBIOTA IN RATS DURING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS].
Paraneoplastic and other autoimmune disorders of the central nervous system.
The Management of Pediatric Multiple Sclerosis.
Factors related to difficulties with employment in patients with multiple sclerosis: a review of 2002-2011 literature.
Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
Oligodendroglial markers in the cuprizone model of CNS de- and remyelination.
Differences In Multiple Sclerosis Relapse Rates Based On Patient Adherence, Average Daily Dose, And Persistence With Disease-Modifying Therapy: Observations Based on Real-World Data.
Acute disseminated encephalomyelitis in Siriraj Hospital: clinical manifestations and short-term outcome.
Simvastatin: two decades in a circle.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Protection of tregs, suppression of Th1 and th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.
Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
Pages
« first
‹ previous
…
203
204
205
206
207
208
209
210
211
…
next ›
last »